Maria R Kamstrup
Overview
Explore the profile of Maria R Kamstrup including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
173
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zeng Z, Vadivel C, Gluud M, Namini M, Yan L, Ahmad S, et al.
J Invest Dermatol
. 2024 May;
144(12):2789-2804.e10.
PMID: 38762064
Cutaneous T-cell lymphoma is characterized by malignant T cells proliferating in a unique tumor microenvironment dominated by keratinocytes (KCs). Skin colonization and infection by Staphylococcus aureus are a common cause...
2.
Vadivel C, Willerslev-Olsen A, Namini M, Zeng Z, Yan L, Danielsen M, et al.
Blood
. 2024 Jan;
143(15):1496-1512.
PMID: 38170178
Patients with Sézary syndrome (SS), a leukemic variant of cutaneous T-cell lymphoma (CTCL), are prone to Staphylococcus aureus infections and have a poor prognosis due to treatment resistance. Here, we...
3.
Pallesen E, Gluud M, Vadivel C, Buus T, de Rooij B, Zeng Z, et al.
J Invest Dermatol
. 2023 Mar;
143(9):1757-1768.e3.
PMID: 36889662
Staphylococcus aureus is suspected to fuel disease activity in cutaneous T-cell lymphomas. In this study, we investigate the effect of a recombinant, antibacterial protein, endolysin (XZ.700), on S. aureus skin...
4.
Gluud M, Pallesen E, Buus T, Gjerdrum L, Lindahl L, Kamstrup M, et al.
Blood
. 2022 Sep;
141(2):180-193.
PMID: 36122387
Cutaneous T-cell lymphoma (CTCL) is a devastating lymphoid malignancy characterized by the accumulation of malignant T cells in the dermis and epidermis. Skin lesions cause serious symptoms that hamper quality...
5.
Willerslev-Olsen A, Gjerdrum L, Lindahl L, Buus T, Pallesen E, Gluud M, et al.
J Invest Dermatol
. 2021 Apr;
141(10):2449-2458.
PMID: 33862068
Staphylococcal enterotoxins are believed to fuel disease activity in cutaneous T-cell lymphoma. Recent data support this by showing that antibiotics inhibit malignant T cells in skin lesions in mycosis fungoides...
6.
Biskup E, Larsen B, Rib L, Folkersen L, Niazi O, Kamstrup M, et al.
Cells
. 2020 Nov;
9(11).
PMID: 33182724
DNA-damaging cancer therapies induce interferon expression and stimulate the immune system, promoting therapy responses. The immune-activating STING (Stimulator of Interferon Genes) pathway is induced when DNA or double-stranded RNA (dsRNA)...
7.
Kamstrup M, Bandier J, Johansen J, Thyssen J
Contact Dermatitis
. 2017 Sep;
77(4):250-251.
PMID: 28872197
No abstract available.
8.
Kamstrup M, Biskup E, Manfe V, Savorani C, Liszewski W, Wiren J, et al.
Leuk Lymphoma
. 2016 May;
58(1):171-178.
PMID: 27181628
The Notch pathway is important for survival of cutaneous T-cell lymphoma (CTCL) cells. We investigated the effect of chemotherapy (doxorubicin, etoposide, and gemcitabine) and radiation modalities on Notch signaling in...
9.
Kamstrup M, Gniadecki R, Iversen L, Skov L, Petersen P, Loft A, et al.
Int J Radiat Oncol Biol Phys
. 2015 Apr;
92(1):138-43.
PMID: 25863761
Purpose: Cutaneous T-cell lymphomas (CTCLs) are dominated by mycosis fungoides (MF) and Sézary syndrome (SS), and durable disease control is a therapeutic challenge. Standard total skin electron beam therapy (TSEBT)...
10.
Biskup E, Manfe V, Kamstrup M, Gniadecki R
Dermatol Reports
. 2014 Nov;
2(1):e8.
PMID: 25386244
We have investigated cell growth dynamics and cyclins B1 and E expression in cell lines derived from mycosis fungoides (MyLa), Sézary syndrome (SeAx), and CD30(+) lympho-proliferative diseases (Mac1, Mac2a, JK)....